Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for DBV Technologies S.A. (DBVT)

« Back to company index

DBVT Chatter Timeline

Stock Ticker for DBVT

Most Active Tweeters for DBVT

UserTweets
@BlueBioNow 3
@Gambiste1 2
@ZolmaxNews 2
@AmericanBanking 2
@WilliamGerber1 1

Recent Tweets for DBVT

otcdynamics @otcdynamics
$DBVT Monthly information regarding the total number of voting rights and total number of shares of the Company https://t.co/vahsyv1Ikr
November 19th 2019, 4:11pm
BlueBioNow @BlueBioNow
$DBVT reasonable changes in stock price 3.92 % change recently https://t.co/uq9xPhY19j
November 18th 2019, 8:11am
dakotafinancial @dakotafinancial
DBV TECHNOLOGIE/S $DBVT Expected to Post Earnings of -$0.47 Per Share https://t.co/TWsG6upT06
November 18th 2019, 1:11am
BlueBioNow @BlueBioNow
$DBVT is on the move with significant price changes 3.92 % https://t.co/uq9xPhY19j
November 17th 2019, 9:11am
IonisDisrupts @IonisDisrupts
@MSollender @semodough $dbvt? So that’s whose supporting the stock. $aimt
November 15th 2019, 6:11am
MSollender @MSollender
@WilliamGerber1 @rocal100 Good catch, that's an error, Baker Bros $DBVT holdings stayed the same; 5,509,560 shares.… https://t.co/xdIIcPLopK
November 14th 2019, 5:11pm
WilliamGerber1 @WilliamGerber1
@rocal100 @MSollender I didn’t see any change in holdings of $DBVT from Q2. Did you see 192% increase?
November 14th 2019, 5:11pm
AmericanBanking @AmericanBanking
Brokerages Anticipate DBV TECHNOLOGIE/S $DBVT Will Post Earnings of -$0.47 Per Share https://t.co/JvUWJeiDXi #stocks
November 12th 2019, 10:11am
ConsumerFeed @ConsumerFeed
Brokerages Anticipate DBV TECHNOLOGIE/S $DBVT Will Post Earnings of -$0.47 Per Share https://t.co/IZbGVc3r3q
November 12th 2019, 10:11am
BlueBioNow @BlueBioNow
$DBVT blockbuster 2.42 % change recently https://t.co/uq9xPhY19j
November 11th 2019, 7:11am
Gambiste1 @Gambiste1
RT @gcassidy718: $DBVT Major changes in stock price 2.42 % change recently https://t.co/yKvCH5rta8
November 10th 2019, 1:11am
gcassidy718 @gcassidy718
$DBVT Major changes in stock price 2.42 % change recently https://t.co/yKvCH5rta8
November 9th 2019, 9:11pm
WatchlistN @WatchlistN
DBV TECHNOLOGIE/S $DBVT Raised to “Hold” at Zacks Investment Research https://t.co/hefXbSnesE
November 9th 2019, 4:11pm
TickerReport @TickerReport
DBV TECHNOLOGIE/S $DBVT Rating Increased to Hold at Zacks Investment Research https://t.co/FnASpexINJ
November 9th 2019, 4:11pm
Gambiste1 @Gambiste1
RT @newsfilterio: Aimmune CFO On Peanut Allergy Candidate Palforzia: 'There Is A Serious Unmet Need' $AIMT $DBVT https://t.co/pTMk9auzPk
November 8th 2019, 4:11am
AmericanBanking @AmericanBanking
DBV TECHNOLOGIE/S $DBVT Given Consensus Rating of “Hold” by Analysts https://t.co/xUDpxSeoxV #stocks
November 8th 2019, 1:11am
ZolmaxNews @ZolmaxNews
DBV TECHNOLOGIE/S $DBVT Given Consensus Rating of “Hold” by Analysts https://t.co/2czlMDIQoH
November 8th 2019, 1:11am
ZolmaxNews @ZolmaxNews
DBV TECHNOLOGIE/S $DBVT Raised to Hold at Zacks Investment Research https://t.co/ooiP2YDS4D
November 7th 2019, 8:11am
dailypoliticaln @dailypoliticaln
DBV TECHNOLOGIE/S $DBVT Rating Increased to Hold at Zacks Investment Research https://t.co/xFxcLY3iFs
November 7th 2019, 8:11am
thomascanon8 @thomascanon8
$MRIN clearly the trade of the day but I must say $DBVT was incredible ?? Nice start to my day to give me a good pa… https://t.co/UwNJl4MZAi
November 6th 2019, 11:11am
biotechradar_eu @biotechradar_eu
$DBV Technologies $DBVT to Present at the Stifel 2019 Healthcare Conference https://t.co/84dor8b99e
November 6th 2019, 2:11am
dakotafinancial @dakotafinancial
DBV TECHNOLOGIE/S $DBVT Upgraded to “Hold” by Zacks Investment Research https://t.co/yOwEgA4UAA
November 5th 2019, 9:11pm
TheMarketsDaily @TheMarketsDaily
DBV TECHNOLOGIE/S $DBVT Rating Increased to Hold at Zacks Investment Research https://t.co/MsrNL7Pl9G
November 5th 2019, 9:11pm
Stock_News_Now @Stock_News_Now
$DBVT: New SEC Filing for DBVT: Form 6-K (No. 0001193125-19-284775): https://t.co/0NHb2w6LAh
November 5th 2019, 4:11pm
otcdynamics @otcdynamics
$DBVT DBV Technologies to Present at the Stifel 2019 Healthcare Conference https://t.co/QGcxTe3Wop
November 5th 2019, 4:11pm
AlertTrade @AlertTrade
RT @Benzinga: Aimmune CFO On Peanut Allergy Candidate Palforzia: 'There Is A Serious Unmet Need' $AIMT $DBVT https://t.co/RRVK0fZB1Y
November 5th 2019, 3:11pm
Benzinga @Benzinga
Aimmune CFO On Peanut Allergy Candidate Palforzia: 'There Is A Serious Unmet Need' $AIMT $DBVT https://t.co/RRVK0fZB1Y
November 5th 2019, 3:11pm
newsfilterio @newsfilterio
Aimmune CFO On Peanut Allergy Candidate Palforzia: 'There Is A Serious Unmet Need' $AIMT $DBVT https://t.co/pTMk9auzPk
November 5th 2019, 12:11pm
AmericanBanking @AmericanBanking
Recent Investment Analysts’ Ratings Updates for DBV TECHNOLOGIE/S $DBVT https://t.co/CcT8PNRgD3 #stocks
November 4th 2019, 7:11pm
TickerReport @TickerReport
Recent Investment Analysts’ Ratings Updates for DBV TECHNOLOGIE/S $DBVT https://t.co/BpYVnpBCNh
November 4th 2019, 7:11pm
BlueBioNow @BlueBioNow
$DBVT I’ll probably buy on the dip. Still need to do more research. -2.77 % https://t.co/uq9xPhY19j
October 31st 2019, 11:10pm
stocknewstimes @stocknewstimes
DBV TECHNOLOGIE/S $DBVT Stock Rating Upgraded by Zacks Investment Research https://t.co/TUzwjGeFWR
October 31st 2019, 10:10pm
newswelldone @newswelldone
$DBVT $WEI: Here’s What Hedge Funds Think About DBV Technologies SA …: https://t.co/ePfuR7WLii
October 30th 2019, 9:10pm
OlympiaReport @OlympiaReport
DBV TECHNOLOGIE/S $DBVT Rating Increased to Hold at Zacks Investment Research https://t.co/khUM6HaWvG
October 30th 2019, 5:10am
dakotafinancial @dakotafinancial
DBV TECHNOLOGIE/S $DBVT Upgraded to “Hold” at Zacks Investment Research https://t.co/byGrmb3fWH
October 29th 2019, 9:10pm
Redrichmond2 @Redrichmond2
RT @Invest1Quantum: @Abeleo9009 FDA hasn’t even accepted $DBVT BLA yet, which they (FDA) could possibly deny it. Furthermore DBVT may also…
October 29th 2019, 3:10pm
AlertTrade @AlertTrade
TREND REVERSAL UP ALERT: $DBVT DBV Technologies SA American ? TradeIdeas via https://t.co/VS8RO0TZ6b to FREE Trading Room
October 29th 2019, 3:10pm
gcassidy718 @gcassidy718
$DBVT might hit  $8.26  soon 3.02 % change recently. https://t.co/yKvCH59SiA
October 29th 2019, 12:10pm
ConsumerFeed @ConsumerFeed
Zacks Investment Research Upgrades DBV TECHNOLOGIE/S $DBVT to Hold https://t.co/jv0cLyU9KR
October 28th 2019, 11:10pm
ConsumerFeed @ConsumerFeed
DBV TECHNOLOGIE/S $DBVT Sees Unusually-High Trading Volume https://t.co/M6t5bqKJYx
October 28th 2019, 9:10pm
gcassidy718 @gcassidy718
$DBVT Long and strong 2.18 % https://t.co/yKvCH5rta8
October 28th 2019, 4:10pm
ConsumerFeed @ConsumerFeed
DBV TECHNOLOGIE/S $DBVT Lifted to “Hold” at Zacks Investment Research https://t.co/hT6KeFt1L7
October 25th 2019, 6:10pm
TickerReport @TickerReport
DBV TECHNOLOGIE/S $DBVT Upgraded to “Hold” by Zacks Investment Research https://t.co/bIbhmKXSr1
October 25th 2019, 6:10pm
biotechradar_eu @biotechradar_eu
$DBV $DBVT Technologies to Highlight the Burden of Peanut Allergy and Patient Experiences with Viaskin Peanut at AC… https://t.co/bjVjZiohst
October 24th 2019, 4:10pm
dispatchtribune @dispatchtribune
Zacks Investment Research Upgrades DBV TECHNOLOGIE/S $DBVT to Hold https://t.co/sKkFUxOdJX
October 24th 2019, 11:10am
OlympiaReport @OlympiaReport
DBV TECHNOLOGIE/S $DBVT Upgraded at Zacks Investment Research https://t.co/ynZccU3ONB
October 24th 2019, 11:10am
macondailynews @macondailynews
Zacks: Analysts Expect DBV TECHNOLOGIE/S $DBVT to Post -$0.47 Earnings Per Share https://t.co/VnQyHpzcjf
October 23rd 2019, 6:10am
TheMarketsDaily @TheMarketsDaily
-$0.47 Earnings Per Share Expected for DBV TECHNOLOGIE/S $DBVT This Quarter https://t.co/0dmghRXsTm
October 23rd 2019, 6:10am
WatchlistN @WatchlistN
DBV TECHNOLOGIE/S $DBVT Rating Increased to Hold at Zacks Investment Research https://t.co/70xVKnSaM2
October 22nd 2019, 9:10pm
HCWCO @HCWCO
#HCWCO recently undersigned acted as a co-manager for $DBVT transaction totaling $143 million. View all of recent t… https://t.co/SALRxGZHPd
October 21st 2019, 9:10am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.